The useful political lesson from Zohran Mamdani’s college application
By Philip Bump,
Washington Post
| 07. 07. 2025
There are a lot of questions worth asking about the New York Times’s report on Thursday about New York City Democratic mayoral nominee Zohran Mamdani. The most obvious is how Mamdani’s racial self-identification in his 2009 application to Columbia University — the university where his father was a tenured professor — has any bearing on his current candidacy. Another is whether the Times should have granted anonymity to the source of the story, a man described by the Guardian as a “proponent of eugenics.” Yet another is whether the news value of the story outweighed its provenance: a hack of personal informationfrom the university by a politically motivated hacker.
But there is nonetheless value to the story: It offers an excellent distillation of the narrow and archaic way Americans evaluate race — both personally and institutionally.
Mamdani’s family is South Asian but lived in Uganda for decades. His father wrote an essay for the London Review of Books in 2022 describing the family’s expulsion from Uganda by Idi Amin and how so many natives of India had come to...
Related Articles
By Keith Casebonne and Jodi Beckstine [with CGS' Katie Hasson], Disability Deep Dive | 07.24.2025
In this episode of Disability Deep Dive, hosts Keith and Jodi explore the complex interplay between disability science, technology, and ethics with guest Katie Hasson, Associate Director at the Center for Genetics and Society. The conversation delves into...
By Angus Liu, Fierce Pharma | 07.22.2025
A brief skirmish between Sarepta Therapeutics and the FDA has ended before escalating into a full-on regulatory clash, as the company has bowed to the agency’s demand.
In a surprising reversal, Sarepta on Monday said it will pause all shipments...
By Lucy Tu, The Atlantic | 07.11.2025
Donald Trump—who is, by his own accounting, “the fertilization president” and “the father of IVF”—wants to help Americans reproduce. During his 2024 campaign, he promised that the government or insurance companies would cover the cost of in vitro fertilization. In...
By Jared Whitlock, Endpoints News | 07.15.2025
Patient groups face a harder and unpredictable path going state-by-state to boost screening for rare but treatable conditions after the Trump administration disbanded a federal advisory committee on newborn screening.
In April, the Advisory Committee on Heritable Disorders in Newborns...